151 related articles for article (PubMed ID: 15769615)
1. Plasminogen activators and plasminogen activator inhibitors in endometriosis.
Gilabert-Estelles J; Castello R; Gilabert J; Ramon LA; Espana F; Romeu A; Estelles A
Front Biosci; 2005 May; 10():1162-76. PubMed ID: 15769615
[TBL] [Abstract][Full Text] [Related]
2. Expression of the fibrinolytic components in endometriosis.
Gilabert-Estelles J; Ramon LA; España F; Gilabert J; Castello R; Estelles A
Pathophysiol Haemost Thromb; 2006; 35(1-2):136-40. PubMed ID: 16855359
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis: the key to new pathogenetic mechanisms.
Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
[TBL] [Abstract][Full Text] [Related]
4. mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay.
Ramón L; Gilabert-Estellés J; Castelló R; Gilabert J; España F; Romeu A; Chirivella M; Aznar J; Estellés A
Hum Reprod; 2005 Jan; 20(1):272-8. PubMed ID: 15579491
[TBL] [Abstract][Full Text] [Related]
5. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis.
Gilabert-Estellés J; Estellés A; Gilabert J; Castelló R; España F; Falcó C; Romeu A; Chirivella M; Zorio E; Aznar J
Hum Reprod; 2003 Jul; 18(7):1516-22. PubMed ID: 12832381
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women.
Bruse C; Bergqvist A; Carlström K; Fianu-Jonasson A; Lecander I; Astedt B
Fertil Steril; 1998 Nov; 70(5):821-6. PubMed ID: 9806560
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.
Braza-Boïls A; Marí-Alexandre J; Gilabert J; Sánchez-Izquierdo D; España F; Estellés A; Gilabert-Estellés J
Hum Reprod; 2014 May; 29(5):978-88. PubMed ID: 24608518
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolysis in the peritoneal fluid during adhesions, endometriosis and ongoing pelvic inflammatory disease.
Edelstam G; Lecander I; Larsson B; Astedt B
Inflammation; 1998 Aug; 22(4):341-51. PubMed ID: 9675606
[TBL] [Abstract][Full Text] [Related]
9. In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue.
Bruse C; Radu D; Bergqvist A
Mol Hum Reprod; 2004 Mar; 10(3):159-66. PubMed ID: 14981142
[TBL] [Abstract][Full Text] [Related]
10. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis.
Cosín R; Gilabert-Estellés J; Ramón LA; Gómez-Lechón MJ; Gilabert J; Chirivella M; Braza-Boïls A; España F; Estellés A
Hum Reprod; 2010 Feb; 25(2):398-405. PubMed ID: 19945964
[TBL] [Abstract][Full Text] [Related]
11. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems.
Gilabert-Estellés J; Ramón LA; España F; Gilabert J; Vila V; Réganon E; Castelló R; Chirivella M; Estellés A
Hum Reprod; 2007 Aug; 22(8):2120-7. PubMed ID: 17609243
[TBL] [Abstract][Full Text] [Related]
12. The role of the peritoneum in the pathogenesis of endometriosis.
Young VJ; Brown JK; Saunders PT; Horne AW
Hum Reprod Update; 2013; 19(5):558-69. PubMed ID: 23720497
[TBL] [Abstract][Full Text] [Related]
13. The role of fibrinolysis in adhesion formation.
Holmdahl L
Eur J Surg Suppl; 1997; (577):24-31. PubMed ID: 9076449
[TBL] [Abstract][Full Text] [Related]
14. [Matrix metalloproteinases and their role in menstruation and endometriosis].
Hudelist G; Singer CF; Keckstein J
Zentralbl Gynakol; 2005 Oct; 127(5):320-4. PubMed ID: 16195977
[TBL] [Abstract][Full Text] [Related]
15. The role of matrix metalloproteinases in the pathogenesis of endometriosis.
Pitsos M; Kanakas N
Reprod Sci; 2009 Aug; 16(8):717-26. PubMed ID: 19351962
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation.
Sharpe-Timms KL; Zimmer RL; Jolliff WJ; Wright JA; Nothnick WB; Curry TE
Fertil Steril; 1998 May; 69(5):916-23. PubMed ID: 9591503
[TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase-type plasminogen activator receptor is over-expressed in uterine endometrium from women with endometriosis.
Sillem M; Prifti S; Monga B; Buvari P; Shamia U; Runnebaum B
Mol Hum Reprod; 1997 Dec; 3(12):1101-5. PubMed ID: 9464855
[TBL] [Abstract][Full Text] [Related]
18. The role of vascular endothelial cells in the regulation of fibrinolysis.
Grulich-Henn J; Müller-Berghaus G
Z Kardiol; 1989; 78 Suppl 6():25-9. PubMed ID: 2694664
[TBL] [Abstract][Full Text] [Related]
19. The role of fibrinolytic system proteins in cholesterol gallstone formation.
Havránek EG; Tierney S; Man WK; Scott-Coombes DM; Thompson JN
Scand J Gastroenterol; 1999 May; 34(5):516-9. PubMed ID: 10423069
[TBL] [Abstract][Full Text] [Related]
20. Paracrine regulation of matrix metalloproteinase expression in endometriosis.
Sharpe-Timms KL; Cox KE
Ann N Y Acad Sci; 2002 Mar; 955():147-56; discussion 157-8, 396-406. PubMed ID: 11949944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
